XtalPi stock jumped over 5% on Thursday.
Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of AI-driven bispecific antibodies for the treatment of various diseases.
Ailux is the biologics innovation arm of XtalPi, specializing in advanced biotherapeutics with AI-powered solutions.